首页> 外文期刊>Journal of Clinical Oncology >Allogeneic Stem-Cell Transplantation in Patients With NPM1-Mutated Acute Myeloid Leukemia: Results From a Prospective Donor Versus No-Donor Analysis of Patients After Upfront HLA Typing Within the SAL-AML 2003 Trial
【24h】

Allogeneic Stem-Cell Transplantation in Patients With NPM1-Mutated Acute Myeloid Leukemia: Results From a Prospective Donor Versus No-Donor Analysis of Patients After Upfront HLA Typing Within the SAL-AML 2003 Trial

机译:NPM1突变急性髓性白血病患者的同种异体干细胞移植:前瞻性供体与患者的未经供体分析在萨尔-AML 2003试验中的初期HLA后的患者患者的结果

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose The presence of a mutated nucleophosmin-1 gene (NPM1(mut)) in acute myeloid leukemia (AML) is associated with a favorable prognosis. To assess the predictive value with regard to allogeneic stem-cell transplantation (SCT), we compared the clinical course of patients with NPM1(mut) AML eligible for allogeneic SCT in a donor versus no-donor analysis.
机译:目的,在急性髓性白血病(AML)中存在突变的核磷素-1基因(NPM1(MUT))与良好的预后有关。 为了评估同种异体干细胞移植(SCT)的预测值,我们将患有NPM1(MUT)AML患者的临床进入患者的临床进入患者与捐赠者分析相反。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号